289 related articles for article (PubMed ID: 38114154)
41. Soluble epoxide hydrolase inhibitor AUDA decreases bleomycin-induced pulmonary toxicity in mice by inhibiting the p38/Smad3 pathways.
Dong XW; Jia YL; Ge LT; Jiang B; Jiang JX; Shen J; Jin YC; Guan Y; Sun Y; Xie QM
Toxicology; 2017 Aug; 389():31-41. PubMed ID: 28694203
[TBL] [Abstract][Full Text] [Related]
42. Ephedrine alleviates bleomycin-induced pulmonary fibrosis by inhibiting epithelial-mesenchymal transition and restraining NF-κB signaling.
Tian H; Wang L; Fu T
J Toxicol Sci; 2023; 48(10):547-556. PubMed ID: 37778983
[TBL] [Abstract][Full Text] [Related]
43. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway.
Luo L; Wang CC; Song XP; Wang HM; Zhou H; Sun Y; Wang XK; Hou S; Pei FY
Biomed Pharmacother; 2018 Sep; 105():841-847. PubMed ID: 30021376
[TBL] [Abstract][Full Text] [Related]
44. Leech extract alleviates idiopathic pulmonary fibrosis by TGF-β1/Smad3 signaling pathway.
Zhang Y; Lu YB; Zhu WJ; Gong XX; Qian R; Lu YJ; Li Y; Yao WF; Bao BH; Zhang Y; Zhang L; Cheng FF
J Ethnopharmacol; 2024 Apr; 324():117737. PubMed ID: 38228229
[TBL] [Abstract][Full Text] [Related]
45. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
46. [Preparation of purified proteins from fresh Pheretima and their inhibitory effect against pulmonary fibrosis in mice].
Li S; Yang Q; Zuo A; Tian L; Huo J; Meng Y; Tang Q; Wang W
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Apr; 42(4):618-624. PubMed ID: 35527500
[TBL] [Abstract][Full Text] [Related]
47. Qilongtian ameliorate bleomycin-induced pulmonary fibrosis in mice via inhibiting IL-17 signal pathway.
Zhang Q; Luo T; Yuan D; Liu J; Fu Y; Yuan J
Sci Rep; 2023 Apr; 13(1):6002. PubMed ID: 37045911
[TBL] [Abstract][Full Text] [Related]
48. Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling.
Zhang YQ; Liu YJ; Mao YF; Dong WW; Zhu XY; Jiang L
Clin Nutr; 2015 Aug; 34(4):752-60. PubMed ID: 25234611
[TBL] [Abstract][Full Text] [Related]
49. KLF2 attenuates bleomycin-induced pulmonary fibrosis and inflammation with regulation of AP-1.
Shi J; Zhou LR; Wang XS; Du JF; Jiang MM; Song Z; Han GC; Mai ZT
Biochem Biophys Res Commun; 2018 Jan; 495(1):20-26. PubMed ID: 29079188
[TBL] [Abstract][Full Text] [Related]
50. Grape seed extract ameliorates bleomycin-induced mouse pulmonary fibrosis.
Liu Q; Jiang JX; Liu YN; Ge LT; Guan Y; Zhao W; Jia YL; Dong XW; Sun Y; Xie QM
Toxicol Lett; 2017 May; 273():1-9. PubMed ID: 28300665
[TBL] [Abstract][Full Text] [Related]
51. Schisandrin B attenuates bleomycin-induced pulmonary fibrosis in mice through the wingless/integrase-1 signaling pathway.
Wang Y; Dong X; Zhao N; Su X; Wang Y; Li Y; Wen M; Li Z; Wang C; Chen J; Zhuang W
Exp Lung Res; 2020; 46(6):185-194. PubMed ID: 32362157
[No Abstract] [Full Text] [Related]
52. Exercise training ameliorates bleomycin-induced epithelial mesenchymal transition and lung fibrosis through restoration of H
Du SF; Wang XL; Ye CL; He ZJ; Li DX; Du BR; Liu YJ; Zhu XY
Acta Physiol (Oxf); 2019 Feb; 225(2):e13177. PubMed ID: 30136377
[TBL] [Abstract][Full Text] [Related]
53. Total polysaccharide of Yupingfeng protects against bleomycin-induced pulmonary fibrosis via inhibiting transforming growth factor-β1-mediated type I collagen abnormal deposition in rats.
Xu L; Li LC; Zhao P; Qi LW; Li P; Gao J; Fei GH
J Pharm Pharmacol; 2014 Dec; 66(12):1786-95. PubMed ID: 25209833
[TBL] [Abstract][Full Text] [Related]
54. Bufei huoxue capsule alleviates bleomycin-induced pulmonary fibrosis in mice via TGF-β1/Smad2/3 signaling.
Li Y; Qin W; Liang Q; Zeng J; Yang Q; Chen Y; Wang J; Lu W
J Ethnopharmacol; 2023 Nov; 316():116733. PubMed ID: 37277082
[TBL] [Abstract][Full Text] [Related]
55. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats.
Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G
Respiration; 2012; 84(6):509-17. PubMed ID: 23006535
[TBL] [Abstract][Full Text] [Related]
56. Nintedanib reduces ventilation-augmented bleomycin-induced epithelial-mesenchymal transition and lung fibrosis through suppression of the Src pathway.
Li LF; Kao KC; Liu YY; Lin CW; Chen NH; Lee CS; Wang CW; Yang CT
J Cell Mol Med; 2017 Nov; 21(11):2937-2949. PubMed ID: 28598023
[TBL] [Abstract][Full Text] [Related]
57. Fucoxanthin inhibits profibrotic protein expression in vitro and attenuates bleomycin-induced lung fibrosis in vivo.
Ma SY; Park WS; Lee DS; Choi G; Yim MJ; Lee JM; Jung WK; Park SG; Seo SK; Park SJ; Han IY; Choi YH; Choi IW
Eur J Pharmacol; 2017 Sep; 811():199-207. PubMed ID: 28642129
[TBL] [Abstract][Full Text] [Related]
58. Therapeutic potential of amitriptyline for paraquat-induced pulmonary fibrosis: Involvement of caveolin-1-mediated anti-epithelial-mesenchymal transition and inhibition of apoptosis.
Chen J; Jian X; Li C; Cheng B
Ecotoxicol Environ Saf; 2023 Apr; 254():114732. PubMed ID: 36898313
[TBL] [Abstract][Full Text] [Related]
59. [Chrysin inhibited epithelial-mesenchymal transition of type Ⅱ alveolar epithelial cell by regulating NF-κB/Twist 1 signaling pathway].
Lu LM; Fu Y; Li QY; He XW; Tang J; Li XW
Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):146-154. PubMed ID: 33645064
[TBL] [Abstract][Full Text] [Related]
60. [Therapeutic effect of Jingfang Granules on CCl_4-induced liver fibrosis in mice and its mechanism].
Li YR; Zhao YF; Cheng GL; Wang EL; Tan YJ; Yao JC; Zhao Y; Zhang GM
Zhongguo Zhong Yao Za Zhi; 2022 Nov; 47(22):6127-6136. PubMed ID: 36471937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
